发明名称 Spiroazacyclic compounds as monoamine receptor modulators
摘要 The present invention relates to 1,3,8-triara-spiro[4.5]decan-2-one compounds as monoamine receptor modulators; compositions comprising the same; methods of inhibiting an activity of a monoamine receptor with said compounds; methods of treating a disease condition associated with a monoamine receptor using said compounds; and methods for identifying a subject suitable for treatment using said compounds.
申请公布号 US7217719(B2) 申请公布日期 2007.05.15
申请号 US20050154083 申请日期 2005.06.16
申请人 ACADIA PHARMACEUTICALS INC. 发明人 SCHLIENGER NATHALIE
分类号 C07D498/10;A61K31/194;A61K31/438;A61K31/5377;A61K31/5386;A61P1/14;A61P3/04;A61P7/02;A61P9/00;A61P9/08;A61P9/10;A61P9/12;A61P25/00;A61P25/06;A61P25/14;A61P25/16;A61P25/18;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/32;A61P43/00;C07D471/10 主分类号 C07D498/10
代理机构 代理人
主权项
地址